DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Robson M, Ruddy KJ, Im SA. et al
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.

Eur J Cancer 2019;
120: 20-30

Download Bibliographical Data

Search in:
Access:
Access: